Asgard Therapeutics’ Financing Round

Roschier represented RV Invest and Johnson & Johnson Innovation on the deal. Asgard Therapeutics AB, a Swedish biotech company pioneering in vivo direct cell reprogramming for...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Avalara’s Public Offer for Pagero

Roschier represented Avalara on the transaction. Avalara, Inc. executed a public offer to the shareholders of Pagero Group AB (publ). The total value of the offer is...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Nordstjernan’s Investment in Ascilion

Roschier represented Nordstjernan in the transaction. Swedish investment company Nordstjernan has invested in Swedish medtech company Ascilion, an investment that makes Nordstjernan the second largest owner...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Insurello’s €15 Million Investment Round

Roschier represented Nordstjernan in the transaction. Swedish InsurTech company Insurello has received a SEK 150m investment. Nordstjernan Growth, a Swedish investment firm, served as the lead investor. Previous...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here